Goldman Sachs’s Agilon Health AGL Stock Holding History

Goldman Sachs’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,380	Closed	-$65.5K	–	6034
2024 Q4	$65.5K	Hold	1,380	–	–	﹤0.01%	5823
2024 Q3	$136K	Hold	1,380	–	–	﹤0.01%	5535
2024 Q2	$226K	Hold	1,380	–	–	﹤0.01%	5211
2024 Q1	$210K	Sell	1,380 -2,600	-65%	-$433K	﹤0.01%	5096
2023 Q4	$1.25M	Hold	3,980	–	–	﹤0.01%	4259
2023 Q3	$1.77M	Hold	3,980	–	–	﹤0.01%	3865
2023 Q2	$1.73M	Buy	3,980 +1,380	+53%	+$776K	﹤0.01%	3977
2023 Q1	$1.54M	Buy	+2,600	New	+$1.46M	﹤0.01%	4056

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's AGL Position: Q1 2026 in Review

Goldman Sachs increased its Agilon Health (AGL) stake by 32% in Q1 2026, buying an estimated $4.2M and bringing the position to 1,062,236 shares worth $8.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3206.

Goldman Sachs first reported a position in AGL in Q3 2021 and has held it in 19 quarters since. The position peaked at $22.5M in Q3 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Goldman Sachs held 1,062,236 shares of Agilon Health worth $8.4M as of Q1 2026.
Goldman Sachs bought 260,027 Agilon Health shares in Q1 2026, an estimated $4.2M.
Agilon Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3206 holding.
Goldman Sachs first reported a position in Agilon Health in Q3 2021 and has held it in 19 quarters since.
Goldman Sachs's Agilon Health position peaked at $22.5M in Q3 2024.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.